Medical ICU, Saint-Louis Hospital AP-HP, Medical ICU, Faculté de médecine, Université Paris-Diderot, Sorbonne Paris-Cité, 1 avenue Claude Vellefaux, 75010 Paris, France.
Intensive Care Med. 2013 Feb;39(2):292-301. doi: 10.1007/s00134-012-2746-2. Epub 2012 Nov 27.
Noninvasive ventilation (NIV) is a treatment option in patients with acute respiratory failure who are good candidates for intensive care but have declined tracheal intubation. The aim of our study was to report outcomes after NIV in patients with a do-not-intubate (DNI) order.
Prospective observational cohort study in all patients who received NIV for acute respiratory failure in 54 ICUs in France and Belgium, in 2010/2011.
Goals of care, comfort, and vital status were assessed daily. On day 90, a telephone interview with patients and relatives recorded health-related quality of life (HRQOL), posttraumatic stress disorder-related symptoms, and symptoms of anxiety and depression. Post-ICU burden was compared between DNI patients and patients receiving NIV with no treatment-limitation decisions (TLD). Of 780 NIV patients, 574 received NIV with no TLD, and 134 had DNI orders. Hospital mortality was 44 % in DNI patients and 12 % in the no-TLD group. Mortality in the DNI group was lowest in COPD patients compared to other patients in the DNI group (34 vs. 51 %, P = 0.01). In the DNI group, HRQOL showed no significant decline on day 90 compared to baseline; day-90 data of patients and relatives did not differ from those in the no-TLD group.
Do-not-intubate status was present among one-fifth of ICU patients who received NIV. DNI patients who were alive on day 90 experienced no decrease in HRQOL compared to baseline. The prevalences of anxiety, depression, and PTSD-related symptoms in these patients and their relatives were similar to those seen after NIV was used as part of full-code management (clinicaltrial.govNCT01449331).
无创通气(NIV)是一种治疗选择,适用于那些适合重症监护但拒绝气管插管的急性呼吸衰竭患者。我们的研究目的是报告有“不插管”(DNI)医嘱的患者接受 NIV 治疗后的结局。
这是一项 2010/2011 年在法国和比利时的 54 家 ICU 中进行的所有接受 NIV 治疗急性呼吸衰竭的患者的前瞻性观察性队列研究。
每天评估患者的治疗目标、舒适度和生命体征。在第 90 天,通过电话采访患者和家属记录健康相关生活质量(HRQOL)、创伤后应激障碍相关症状以及焦虑和抑郁症状。将 DNI 患者与未进行治疗限制决策(TLD)的接受 NIV 治疗的患者的 ICU 后负担进行比较。在 780 名接受 NIV 的患者中,574 名患者未进行 TLD,134 名患者有 DNI 医嘱。DNI 患者的院内死亡率为 44%,无 TLD 组为 12%。在 DNI 组中,与 DNI 组中的其他患者相比,COPD 患者的死亡率最低(34%比 51%,P=0.01)。在 DNI 组中,与基线相比,第 90 天的 HRQOL 没有显著下降;患者和家属的第 90 天数据与无 TLD 组没有差异。
在接受 NIV 的 ICU 患者中,有五分之一的患者存在 DNI 状态。在第 90 天存活的 DNI 患者与基线相比,HRQOL 没有下降。这些患者及其家属的焦虑、抑郁和创伤后应激障碍相关症状的发生率与作为全编码管理一部分使用 NIV 后的发生率相似(clinicaltrial.govNCT01449331)。